Hunan Hansen Pharmaceutical Co. Ltd. (002412.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 8.95

From 52W high−20.04%

Volume57.26M

Market capCNY 5.64B

P/E (TTM)28.5x

P/S (TTM)4.4x

Div yield3.32%

Key dataSep 18, 2026

Open

CNY 8.95

From 52W high

−20.04%

Volume

57.26M

Market cap

CNY 5.64B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.8x

P/E (TTM)

28.5x

RSI (14)

47.3

MomentumView details →

1D Return

+10.01%

YTD Return

+41.03%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

28.5x

EV/EBITDA

15.8x

EV/Sales

4.3x

P/S (TTM)

4.4x

P/B (TTM)

2.5x

ProfitabilityView details →

Gross Margin

78.06%

Net Margin

21.81%

EBITDA Margin

27.18%

ROE (TTM)

9.30%

ROA (TTM)

8.24%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

+1.27%

EPS YoY

+30.02%

FCF YoY

+20.01%

Revenue CAGR 3Y

+4.28%

EPS CAGR 3Y

+5.73%

EBITDA YoY

—

MomentumView details →

1D Return

+10.01%

YTD Return

+41.03%

1Y Return

+39.51%

RSI (14)

47.3

vs 50D SMA

+6.88%

vs 200D SMA

+26.45%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

4.80x

Quick Ratio

4.05x

Div Yield

3.32%

Div Rate

CNY 0.30

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.03B

Net Income (TTM)

225.27M

Op. CF (TTM)

185.55M

Latest newsMore news →

Hansen Pharmaceutical plans to inject 20 million yuan of its own funds into its wholly owned subsidiary Hansen Health Industry (Hunan) Co., Ltd., raising the subsidiary's registered capital from 240 million yuan to 260 million yuan while retaining 100% ownership.7d ago

Hansen Pharmaceutical completed the change registration of its Drug Manufacturing License, obtaining a new license from the Hunan Provincial Drug Administration, valid until November 6, 2030.25d ago

Similar companies

广东鸿图002101.SZ 红棉股份000523.SZ 铭普光磁002902.SZ 精锻科技300258.SZ 精华制药002349.SZ 常宝股份002478.SZ Find similar companies →

Latest newsMore news →

Hansen Pharmaceutical plans to inject 20 million yuan of its own funds into its wholly owned subsidiary Hansen Health Industry (Hunan) Co., Ltd., raising the subsidiary's registered capital from 240 million yuan to 260 million yuan while retaining 100% ownership.7d ago Hansen Pharmaceutical completed the change registration of its Drug Manufacturing License, obtaining a new license from the Hunan Provincial Drug Administration, valid until November 6, 2030.25d ago